Dr. Sarah E. Glorioso, MD

Dr. Glorioso practices at WK Dermatology Clinic in Bossier City, Louisiana.

Dr. Glorioso's NPI, 1093916140, was assigned on May 29, 2007. Dr. Glorioso graduated from Louisiana State University School of Medicine in New Orleans in 2005. Dr. Glorioso holds Louisiana license MD.201108.

Dr. Glorioso's primary practice is WK Dermatology Clinic, at 2300 Hospital Dr, Bossier City, LA 71111 in Bossier Parish. The practice phone is (318) 212-7800.

Dr. Glorioso's primary practice is WK Dermatology Clinic in Bossier City, Louisiana. Dr. Glorioso is also affiliated with Willis Knighton North. The medical group on file is Ark-La-Tex Dermatology - Bossier City. Dmand AI also links Dr. Glorioso to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Glorioso practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Glorioso's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Glorioso is licensed in Louisiana.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Glorioso treats.

CMS data shows 12,855 Medicare services from Dr. Glorioso across 31 procedure codes in 2024, for 1,633 Medicare patients. Medicare paid $406,223 for them. Every service was in an office.

CMS counts 1,633 Medicare patients who saw Dr. Glorioso in 2024. The largest group is 65 to 74, with 786 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Glorioso's median patient age at 62, with 61% women.

In 2024, Dr. Glorioso wrote 2,161 Medicare Part D claims for 697 patients. 91% of them were for generic drugs. CMS names the drug for 1,936 of them, across 33 drugs with 11 or more claims each, at $1,043,128 in total drug cost. In 2023, CMS named 1,741 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Glorioso for performance year 2024, reported through an alternative payment model (APM). Dr. Glorioso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,249 procedures of removal of skin lesions by Dr. Glorioso, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Glorioso. Dr. Glorioso's most frequent co-author is Allyson Jones Kopel, MD.

CMS Open Payments shows 582 general payments to Dr. Glorioso from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $1,803.

Dmand AI lists 1 award for Dr. Glorioso.

Dr. Glorioso graduated from Louisiana State University School of Medicine in New Orleans in 2005.

Dr. Glorioso is in network with 14 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.